Characteristic | Details |
---|---|
Sex | 66.6% female |
Age (years [mean ± SD]) | 56.8 ± 11.2 |
Disease duration (months [mean ± SD]) | 6.4 ± 3.0 |
Bone erosion (% of patients) | 100% |
RF IgM (% of patients) | 50% |
RF IgA (% of patients) | 50% |
Anti-CCP (% of patients) | 100% |
Remission according to DAS (% of patients) | 50% |